Lactobacillus plantarum displaying CCL3 chemokine in fusion with HIV-1 Gag derived antigen causes increased recruitment of T cells.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4618854)

Published in Microb Cell Fact on October 22, 2015

Authors

Katarzyna Kuczkowska1, Geir Mathiesen1, Vincent G H Eijsink1, Inger Øynebråten2

Author Affiliations

1: Department of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), P.O. Box 5003, 1432, Ås, Norway. geir.mathiesen@nmbu.no.
2: Department of Pathology and Centre for Immune Regulation, Oslo University Hospital-Rikshospitalet, and University of Oslo, Oslo, Norway. geir.mathiesen@nmbu.no.

Articles cited by this

Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (1985) 30.62

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med (2006) 10.34

International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev (2000) 7.17

Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol (2006) 6.30

Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature (2006) 5.19

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients. Nature (2015) 3.46

Macrophage inflammatory protein-1. Int J Biochem Cell Biol (2004) 3.15

Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry (1997) 2.87

Chemokines in pathology and medicine. J Intern Med (2001) 2.83

Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol (2014) 2.71

Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol (2008) 2.58

Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A (2005) 2.35

Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes. J Virol (2009) 1.80

High-level, inducible gene expression in Lactobacillus sakei and Lactobacillus plantarum using versatile expression vectors. Microbiology (2005) 1.63

Transformation of Lactobacillus by electroporation. Methods Mol Biol (1995) 1.58

Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization. PLoS One (2010) 1.56

The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle. J Biol Chem (2002) 1.46

Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines. Microb Cell Fact (2011) 1.45

Immunomodulatory mechanisms of lactobacilli. Microb Cell Fact (2011) 1.40

Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function. Exp Cell Res (2011) 1.35

Recruitment of different subsets of antigen-presenting cells selectively modulates DNA vaccine-elicited CD4+ and CD8+ T lymphocyte responses. Eur J Immunol (2004) 1.23

Construction of vectors for inducible gene expression in Lactobacillus sakei and L plantarum. FEMS Microbiol Lett (2003) 1.22

Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env. Blood (2003) 1.20

A global approach to HIV-1 vaccine development. Immunol Rev (2013) 1.14

Heterologous protein secretion by Lactobacillus plantarum using homologous signal peptides. J Appl Microbiol (2008) 1.01

Touch of chemokines. Front Immunol (2012) 1.00

Lactic acid bacteria--20 years exploring their potential as live vectors for mucosal vaccination. Appl Microbiol Biotechnol (2015) 0.96

Dissimilar properties of two recombinant Lactobacillus acidophilus strains displaying Salmonella FliC with different anchoring motifs. Appl Environ Microbiol (2011) 0.95

Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update. FEMS Microbiol Lett (2013) 0.95

Cell wall anchoring of the 37-kilodalton oncofetal antigen by Lactobacillus plantarum for mucosal cancer vaccine delivery. Appl Environ Microbiol (2010) 0.95

Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences. Blood (2007) 0.94

Effects of MIP-1 alpha, MIP-3 alpha, and MIP-3 beta on the induction of HIV Gag-specific immune response with DNA vaccines. Mol Ther (2007) 0.92

Purification and identification of chemokines potentially involved in kidney-specific metastasis by a murine lymphoma variant: induction of migration and NFkappaB activation. Int J Cancer (1998) 0.92

High-level expression of recombinant beta-galactosidases in Lactobacillus plantarum and Lactobacillus sakei using a Sakacin P-based expression system. J Agric Food Chem (2008) 0.91

Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1. Clin Exp Immunol (1999) 0.91

Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery. Clin Vaccine Immunol (2012) 0.89

Pathomechanisms: homeostatic chemokines in health, tissue regeneration, and progressive diseases. Trends Mol Med (2014) 0.88

Role of the autocrine chemokines MIP-1alpha and MIP-1beta in the metastatic behavior of murine T cell lymphoma. J Leukoc Biol (2002) 0.88

Surface display of N-terminally anchored invasin by Lactobacillus plantarum activates NF-κB in monocytes. Appl Environ Microbiol (2012) 0.88

The N-terminal domain of CCL21 reconstitutes high affinity binding, G protein activation, and chemotactic activity, to the C-terminal domain of CCL19. Biochem Biophys Res Commun (2006) 0.86

DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza. J Immunol (2013) 0.85

Generation of antibody-producing hybridomas following one single immunization with a targeted DNA vaccine. Scand J Immunol (2012) 0.84

Chemokine oligomerization in cell signaling and migration. Prog Mol Biol Transl Sci (2013) 0.83

Development of vaccine delivery vehicles based on lactic acid bacteria. Mol Biotechnol (2012) 0.82

The specificity of targeted vaccines for APC surface molecules influences the immune response phenotype. PLoS One (2013) 0.82

Generation of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvant. Hum Vaccin Immunother (2012) 0.81

Chemokines as Cancer Vaccine Adjuvants. Vaccines (Basel) (2013) 0.81

Production of biologically active CXC chemokines by Lactococcus lactis: evaluation of its potential as a novel mucosal vaccine adjuvant. Vaccine (2008) 0.80

Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge. Mucosal Immunol (2015) 0.80

Oligomerized, filamentous surface presentation of RANTES/CCL5 on vascular endothelial cells. Sci Rep (2015) 0.79

Murine interferon-gamma inducible protein-10 (IP-10) secreted by Lactococcus lactis chemo-attracts human CD3+ lymphocytes. Biotechnol Lett (2009) 0.77

Increased generation of HIV-1 gp120-reactive CD8+ T cells by a DNA vaccine construct encoding the chemokine CCL3. PLoS One (2014) 0.77

Safety of a nasal vaccine against Streptococcus pneumoniae using heat-killed Lactobacillus casei as adjuvant. Immunobiology (2014) 0.77

Production of biologically active human lymphotactin (XCL1) by Lactococcus lactis. Biotechnol Lett (2008) 0.76